(VIANEWS) – Arcelor Mittal (MT), H. B. Fuller Company (FUL), GoPro (GPRO) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Arcelor Mittal (MT)

47.1% sales growth and 18.21% return on equity

ArcelorMittal, together with its subsidiaries, owns and operates steel manufacturing and mining facilities in Europe, North and South America, Asia, and Africa.

Arcelor Mittal’s sales growth this year is anticipated to be 46.1% and a negative 11.5% for next year.

Year-on-year quarterly revenue growth grew by 76.2%, now sitting on 62.99B for the twelve trailing months.

Volume

Today’s last reported volume for Arcelor Mittal is 4974380 which is 17.7% above its average volume of 4226240.

Arcelor Mittal’s sales growth for the next quarter is 47.1%. The company’s growth estimates for the ongoing quarter and the next is 2536.8% and 1826.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.

Volatility

Arcelor Mittal’s last day, last week, and last month’s current intraday variation average was 0.99%, 1.90%, and 2.38%, respectively.

Arcelor Mittal’s highest amplitude of average volatility was 2.40% (day), 2.27% (last week), and 2.16% (last month), respectively.

Arcelor Mittal’s Stock Yearly Top and Bottom Value

Arcelor Mittal’s stock is valued at $35.62 at 00:22 EST, under its 52-week high of $36.58 and way higher than its 52-week low of $20.50.

Arcelor Mittal’s Moving Average

Arcelor Mittal’s value is way above its 50-day moving average of $30.75 and way above its 200-day moving average of $30.93.

2. H. B. Fuller Company (FUL)

19.9% sales growth and 10.49% return on equity

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide.

H. B. Fuller Company’s sales growth this year is expected to be 17.5% and 7.9% for next year.

Year-on-year quarterly revenue growth grew by 19.6%, now sitting on 3.16B for the twelve trailing months.

Volume

Today’s last reported volume for H. B. Fuller Company is 172444 which is 32.22% below its average volume of 254420.

H. B. Fuller Company’s sales growth for the next quarter is 19.9%. The company’s growth estimates for the present quarter and the next is 1.9% and 15.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.49%.

Volatility

H. B. Fuller Company’s last day, last week, and last month’s current intraday variation average was 0.70%, 1.00%, and 1.04%, respectively.

H. B. Fuller Company’s highest amplitude of average volatility was 1.32% (day), 1.39% (last week), and 1.76% (last month), respectively.

H. B. Fuller Company’s Stock Yearly Top and Bottom Value

H. B. Fuller Company’s stock is valued at $81.00 at 00:22 EST, under its 52-week high of $81.73 and way above its 52-week low of $49.80.

H. B. Fuller Company’s Moving Average

H. B. Fuller Company’s value is above its 50-day moving average of $75.88 and way higher than its 200-day moving average of $68.13.

3. GoPro (GPRO)

13.4% sales growth and 29.44% return on equity

GoPro, Inc. develops and sells cameras, drones, and mountable and wearable accessories in the United States and internationally.

GoPro’s sales growth this year is expected to be 28.7% and 7.8% for next year.

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 1.09B for the twelve trailing months.

Volume

Today’s last reported volume for GoPro is 2886800 which is 4.29% above its average volume of 2767960.

GoPro’s sales growth for the next quarter is 13.4%. The company’s growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.44%.

Volatility

GoPro’s last day, last week, and last month’s current intraday variation average was 3.20%, 1.86%, and 1.84%, respectively.

GoPro’s highest amplitude of average volatility was 4.33% (day), 3.81% (last week), and 3.83% (last month), respectively.

GoPro’s Stock Yearly Top and Bottom Value

GoPro’s stock is valued at $9.70 at 00:22 EST, way under its 52-week high of $13.79 and way above its 52-week low of $7.02.

GoPro’s Moving Average

GoPro’s worth is below its 50-day moving average of $9.75 and below its 200-day moving average of $10.53.

4. Integra LifeSciences Holdings Corporation (IART)

9.1% sales growth and 14.29% return on equity

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery.

Integra LifeSciences Holdings Corporation’s sales growth this year is expected to be 12.3% and 5.8% for next year.

Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 1.53B for the twelve trailing months.

Volume

Today’s last reported volume for Integra LifeSciences Holdings Corporation is 101746 which is 71.03% below its average volume of 351284.

Integra LifeSciences Holdings Corporation’s sales growth for the next quarter is 9.1%. The company’s growth estimates for the current quarter and the next is a negative 1.2% and 10.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.29%.

Volatility

Integra LifeSciences Holdings Corporation’s last day, last week, and last month’s current intraday variation average was 0.38%, 2.17%, and 1.55%, respectively.

Integra LifeSciences Holdings Corporation’s highest amplitude of average volatility was 3.05% (day), 3.45% (last week), and 2.94% (last month), respectively.

Integra LifeSciences Holdings Corporation’s Stock Yearly Top and Bottom Value

Integra LifeSciences Holdings Corporation’s stock is valued at $65.53 at 00:22 EST, way below its 52-week high of $77.40 and higher than its 52-week low of $61.85.

Integra LifeSciences Holdings Corporation’s Moving Average

Integra LifeSciences Holdings Corporation’s worth is below its 50-day moving average of $67.29 and under its 200-day moving average of $69.58.

5. Norfolk Southern (NSC)

8.3% sales growth and 15.61% return on equity

Norfolk Southern Corporation, together with its subsidiaries, engages in the rail transportation of raw materials, intermediate products, and finished goods in the United States.

Norfolk Southern’s sales growth this year is expected to be 12.7% and 5.7% for next year.

Year-on-year quarterly revenue growth grew by 0.5%, now sitting on 9.8B for the twelve trailing months.

Volume

Today’s last reported volume for Norfolk Southern is 1212340 which is 4.71% above its average volume of 1157770.

Norfolk Southern’s sales growth is a negative 0% for the present quarter and 8.3% for the next. The company’s growth estimates for the current quarter and the next is 21.5% and 14.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.61%.

Volatility

Norfolk Southern’s last day, last week, and last month’s current intraday variation average was 0.82%, 2.26%, and 1.16%, respectively.

Norfolk Southern’s highest amplitude of average volatility was 1.86% (day), 3.41% (last week), and 2.21% (last month), respectively.

Norfolk Southern’s Stock Yearly Top and Bottom Value

Norfolk Southern’s stock is valued at $278.06 at 00:22 EST, under its 52-week high of $296.06 and way above its 52-week low of $226.09.

Norfolk Southern’s Moving Average

Norfolk Southern’s value is above its 50-day moving average of $269.34 and above its 200-day moving average of $267.33.

LEAVE A REPLY

Please enter your comment!
Please enter your name here